INVENTISBIO
InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company is co-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
INVENTISBIO
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.inventisbio.com
Total Employee:
1+
Status:
Active
Total Funding:
247 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Wordpress Plugins Nginx Euro Microsoft Exchange Online
Similar Organizations
Genevide
Genevide is a biotech company that specializes in gene research and development.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Teligene
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.
Current Advisors List
Board_member
Current Employees Featured
Xing Dai Co-Founder and Head of Chemistry @ InventisBio
Co-Founder and Head of Chemistry
2015-01-01
Yaolin Wang Founder,Chairman & CEO @ InventisBio
Founder,Chairman & CEO
Founder
Stock Details
Investors List
Dyee Capital
Dyee Capital investment in Series D - InventisBio
Janchor Partners
Janchor Partners investment in Series D - InventisBio
Qiming Venture Partners
Qiming Venture Partners investment in Series D - InventisBio
E Fund Management Co.,LTD.
E Fund Management Co.,LTD. investment in Series D - InventisBio
Pudong Innotek
Pudong Innotek investment in Series D - InventisBio
Matrix Partners China
Matrix Partners China investment in Series D - InventisBio
Lilly Asia Ventures
Lilly Asia Ventures investment in Series D - InventisBio
GL Ventures
GL Ventures investment in Series D - InventisBio
CMB International Capital Corporation
CMB International Capital Corporation investment in Series D - InventisBio
Advantech Capital
Advantech Capital investment in Series D - InventisBio
Official Site Inspections
http://www.inventisbio.com
- Host name: 139.224.229.15
- IP address: 139.224.229.15
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "InventisBio"
InventisBio - Crunchbase Company Profile & Funding
InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively …See details»
益方生物科技（上海）股份有限公司 - inventisbio.com
InventisBio is a clinical stage biotech company with two drugs approved and three candidates in clinical trials with the most advanced one in a phase 3 registration trials in China. We are …See details»
益方生物科技（上海）股份有限公司
益方生物是一家立足中国具有全球视野的创新型药物研发企业。公司的产品主要聚焦于肿瘤、代谢及自身免疫性疾病等重大 ...See details»
Company Introduction – 益方生物科技（上海）股份有限公司
InventisBio is a clinical stage biotech company with two drugs approved and three candidates in clinical trials with the most advanced one in a phase 3 registration trials in China. We are …See details»
InventisBio (SHA:688382) Company Profile & Description - Stock …
1 day ago InventisBio Company Description InventisBio Co., Limited, a clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic …See details»
InventisBio Inc. (CN) - [LSUS] Life-Sciences-USA.com - The ...
Jan 1, 2016 InventisBio is a clinical stage biotech company dedicated to the discovery and development of novel therapeutics against cancer and metabolic diseases. The company has …See details»
InventisBio, Co., Ltd. - Drug pipelines, Patents, Clinical trials
InventisBio also noted that 50% of patients receiving the highest dose of the drug saw a complete clearance of the skin by week 12. The complete data are set to be presented at an upcoming …See details»
InventisBio Company Profile - Office Locations, Competitors ... - Craft
InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer, and gout. The Company is also actively …See details»
InventisBio - Crunchbase
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs. ... Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AI …See details»
InventisBio, Co., Ltd.
了解InventisBio, Co., Ltd. (益方生物科技（上海）股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的43项临床试验, 21篇新闻和1篇文献，疾病领域:肿瘤，免疫系统疾病，内分泌 …See details»
Inventisbio - Overview, News & Similar companies | ZoomInfo.com
Apr 11, 2022 Who is Inventisbio. InventisBio is a fast-growing innovative biotech company, co-founded by Dr. Yaolin Wang and other senior scientists. The company's top management t …See details»
InventisBio Company Profile & Introduction - moomoo
Jan 11, 2013 About InventisBio Company. The company is an innovative drug research and development enterprise with a global perspective based in China, focusing on major diseases …See details»
InventisBio - Funding, Financials, Valuation & Investors - Crunchbase
InventisBio is registered under the ticker SSE:688382 . Their stock opened with CN¥18.12 in its Jul 24, 2022 IPO. Stock Symbol SSE:688382 ; Valuation at IPO CN¥10.4B; Money Raised at …See details»
InventisBio - Company Profile - Tracxn
Feb 25, 2025 InventisBio - Developer of small molecule drug candidates for the treatment of lung cancer, breast cancer and gout. Raised a total funding of $247M over 5 rounds from 13 …See details»
InventisBio | VentureRadar
InventisBio focuses on discovery and development of novel therapeutics in the areas of oncology and metabolic diseases to address unmet medical needs. The company was founded by a …See details»
InventisBio - Products, Competitors, Financials, Employees ...
InventisBio's products are in various stages of clinical trials, including one product in the NDA application stage and four in the clinical trial phase. It was founded in 2013 and is based in …See details»
InventisBio 2025 Company Profile: Stock Performance & Earnings
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It …See details»
Organization: InventisBio - Cbonds.com
InventisBio Co., Ltd. develops biotechnology products. The Company produces tumor drugs, metabolic drugs, lung cancer drugs, breast cancer drugs, gout drugs, and other related …See details»
InventisBio - Contacts, Employees, Board Members, Advisors
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs. ... Experience the new Crunchbase, powered by AI . …See details»
InventisBio Announces $147 Million Series D Financing Led by …
Sep 27, 2020 InventisBio is a fast-growing innovative biotech company, co-founded by Dr. Yaolin Wang and other senior scientists. The company's top management team members …See details»